Filing Flows › Kestra Medical Technologies (KMTS) › Q1 FY27 › vs Q1 FY26
Kestra Medical Technologies (KMTS) Q1 FY27 vs Q1 FY26 (year over year)
Kestra Medical Technologies's revenue rose $11.6M (+60%) from $19.4M in Q1 FY26 to $31.0M in Q1 FY27.
Kestra Medical Technologies, Q1 FY27: revenue $31.0M (+60% year over year), operating margin -121.6%, net loss $44.1M, operating cash flow −$32.3M. The chart draws each line against Q1 FY26, the increases inside each band.
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $31.0M | $19.4M | $11.6M | +60% |
| Net loss | $44.1M | $25.8M | $18.3M | +71% |
| Costs & expenses | $75.1M | $48.3M | $26.8M | +55% |
| Operating costs | $68.6M | $48.2M | $20.4M | +42% |
| Interest & other, net | $6.4M | −$3.1M | $9.5M | — |
| Income tax | $50K | $33K | $17K | +52% |
| Cost of revenue | $13.5M | $10.5M | $3.0M | +28% |
| Research & development | $6.8M | $4.0M | $2.8M | +70% |
| SG&A | $48.4M | $33.7M | $14.6M | +43% |
| Operating cash sources | $44.5M | $32.9M | $11.6M | +35% |
| Depreciation | $2.7M | $2.0M | $636K | +31% |
| Share-based compensation | $9.5M | $4.6M | $4.9M | +108% |
| Cash used in operations | $32.3M | $26.3M | $6.0M | +23% |
| Net loss absorbed | $44.1M | $25.8M | $18.3M | +71% |
| Working capital & other | $389K | $7.1M | −$6.7M | -94% |
Questions
How much did Kestra Medical Technologies's revenue grow year over year in Q1 FY27?
Kestra Medical Technologies's revenue rose $11.6M (+60%) from $19.4M in Q1 FY26 to $31.0M in Q1 FY27.